About the Journal

Focus and Scope

Journal of Diabetes and Endocrinology Association of Nepal is biannual Open Access peer reviewed indexed and open access international journal. It is an official journal of the Diabetes and Endocrinology Association of Nepal and is published with the sole aim of promoting and sharing quality medical information.

The journal publishes reports of experimental and clinical research on Diabetes and Endocrinology. It publishes in several key aspects in this field by including research on topics like Diabetes Mellitus, Diabetes Insipidus, Diabetes Complications, Hypoglycemia and Hyperglycemia, Diabetes Treatment and Cure, Gestational Diabetes, Endocrine System, Endocrinal Disorders, Hyperthyroidism, Pediatric Endocrinology, and Hormone Replacement Therapy.

The journal encourages advancements in the areas not limited to the one mentioned above in the form of research articles, reviews, commentaries, case studies and short communication. The Editorial, Guest Editorial and Letter to the Editor are solicited by the editorial board. Manuscripts that are thoroughly peer reviewed would ensure the best standards in the industry.

Authors do not have to pay for submission, processing or publication of articles in JDEAN.

The Editorial Process

A manuscript that is submitted will be initially reviewed for possible publication by the Editors with the understanding that it has not been published anywhere, simultaneously submitted, or already accepted for publication elsewhere. The journal expects that authors would authorize one of them to correspond with the journal for all matters related to the manuscript. All manuscripts received are duly acknowledged. Editors will review all submitted manuscripts initially for suitability for formal review. Manuscripts with insufficient originality, serious scientific or technical flaws, or lack of significant message are rejected. In the case of a good article that has been written poorly, the authors are asked to resubmit after revision.

Peer Review Process

The potentially suitable manuscript selected for publication are sent to two or more expert reviewers blinded to the contributor’s identity and vice versa for meticulous review, inputs and comments. The final decision on whether to accept or reject the article are taken by the Editor-in-Chief based on editorial board and peer reviewers. The contributors are informed about the rejection/acceptance of the manuscript with the peer reviewer’s comments. Accepted articles have to be resubmitted after making the necessary changes or clarifying questions made during the peer review process.

See the Submission Guidelines for more information...

Publication Frequency

The journal is published bi-annually.

Open Access Policy

The Journal of Diabetes and Endocrinology Association of Nepal (JDEAN) is committed to real and immediate open access for academic work. All of the JDEAN articles are free to access immediately from the date of publication. The journal allows readers to freely read, download, copy, distribute, print, search, or link to the full texts of its articles and to use them for any other lawful purpose provided the authors and journal are properly cited.

Creative Commons Licence
The articles in the Journal of Diabetes and Endocrinology Association of Nepal are licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. 

Publishing your research article as an open access article with this publisher will mean that it:

  • It is peer-reviewed.
  • It has rapid publication.
  • It is immediately accessible online upon publication free of charge.
  • Authors retain copyright of their work.
  • The article can be shared and used by readers as defined by your user license. The published material can be re-used without obtaining permission as long as a correct citation to the original publication is given.
  • Free access for users worldwide.
  • Increased visibility and readership.

Plagiarism policy of JDEAN

The authors should make sure that submitted work is original and their own. If authors have used work and/or words of others then they should be appropriately cited or quoted. Plagiarism constitutes many forms, from ‘passing off’ another’s paper as the author’s own paper, to copying or paraphrasing substantial parts of another’s paper (without attribution), to claiming results from research conducted by others. Plagiarism in all its forms is unethical and unacceptable. JDEAN editors make use of Small SE Tools Plagiarism Checker  for plagiarism detection and we also suggest our authors check the same if possible before submission to JDEAN.

Subscription Rates

The following subscription rates exclude postage charges.

Subscription Payments should be sent in the form of a Bank Draft in the name of Diabetes and Endocrinology Association of Nepal.

Authors do not have to pay for submission, processing or publication of articles in JDEAN.

Nepal
Institutional
Annual: Nrs. 2000, Per Copy: Nrs. 1000
Individual
Annual: Nrs. 1000, Per Copy: Nrs. 500

SAARC Countries
Institutional
Annual: USD 100, Per Copy: USD 50
Individual
Annual: USD 60, Per Copy: USD 30

International Subscrition
Institutional
Annual: USD 160, Per Copy: USD 80
Individual
Annual: USD 100, Per Copy: USD 50

Disclaimers

JDEAN discloses the following disclaimers.

  1. The information, opinions and views presented in the Journal of Diabetes and Endocrinology Association of Nepal reflect the views of the authors and contributors of the articles and not of the Journal of Diabetes and Endocrinology Association of Nepal or the Editorial Board or its publishers
  2. Publication of articles, advertisements or product information does not constitute endorsement or approval by the journal and/or its publisher.
  3. The Journal of Diabetes and Endocrinology Association of Nepal and/or its publisher cannot be held responsible for any errors or for any consequences arising from the use of the information contained in this journal.
  4. Although every effort is made by the editorial board and the publishers to see that no inaccurate or misleading data, opinion or statement appear in this journal, the data and opinions appearing in the articles including editorials and advertisements herein are the responsibility of the contributors concerned.
  5. The publishers and the editorial board accept no liability whatsoever for the consequences of any such inaccurate or misleading data, information, opinion or statement.
  6. Whilst every effort is made by the editorial board and the publishers to ensure that drug doses and other quantities are presented accurately, readers are advised that new methods and techniques involving drug usage as described in this journal, should only be followed in conjunction with the drug manufacturer's own published literature in their own country.